Mosaicism in the skin: The importance of mild or minimal skin lesions

Archives of Dermatology

Volumn 147, Issue 9, 2011, Pages 1094-1096

  Has, Cristina ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3BETA HYDROXYSTEROL DELTA8, DELTA7 ISOMERASE; BINDING PROTEIN; EMOPAMIL BINDING PROTEIN; STEROID DELTA ISOMERASE; UNCLASSIFIED DRUG;

CALCIFYING CHONDRODYSTROPHY; CATARACT; CHONDRODYSPLASIA PUNCTATA; CHROMOSOME MOSAICISM; CLINICAL FEATURE; DISEASE TRANSMISSION; EBP GENE; EDITORIAL; GENE; GENE MUTATION; GENETIC VARIABILITY; HERITABILITY; HETEROZYGOSITY; HUMAN; PRIORITY JOURNAL; SHORT STATURE; SKELETON MALFORMATION; SKIN DEFECT; SOMATIC MUTATION; X CHROMOSOME INACTIVATION;

CHONDRODYSPLASIA PUNCTATA; FEMALE; HUMANS; MOSAICISM; MUTATION; STEROID ISOMERASES;

EID: 80053089963     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2011.233     Document Type: Editorial

References (27)

1. Frank J, Happle R. Cutaneous mosaicism: right before our eyes. J Clin Invest. 2007;117(5):1216-1219. (Pubitemid 46718407)
2. Happle R. X-linked dominant chondrodysplasia punctata: review of literature and report of a case. Hum Genet. 1979;53(1):65-73. (Pubitemid 10173687)
3. Happle R, Lenz W. Striation of bones in focal dermal hypoplasia: manifestation of functional mosaicism? Br J Dermatol. 1977;96(2):133-135.
4. Happle R. Skin markers of X-linked dominant chondrodysplasia punctata. Arch Dermatol. 1979;115(8):931-932.
5. Happle R, Kästner H. X-linked dominant chondrodysplasia punctata: an osteocutaneous syndrome. Hautarzt. 1979;30(11):590-594. (Pubitemid 10200867)
6. Happle R. The lines of Blaschko: a developmental pattern visualizing functional X-chromosome mosaicism. Curr Probl Dermatol. 1987;17:5-18.
7. Morice-Picard F, Kostrzewa E, Wolf C, Benlian P, Taïeb A, Lacombe D. Evidence of postzygotic mosaicism in a transmitted form of Conradi- Hünermann-Happle syndrome associated with a novel EBP mutation. Arch Dermatol. 2011;147 (9):1073-1076.
8. Traupe H, Has C. The Conradi-Hünermann-Happle syndrome is caused by mutations in the gene that encodes a 8-7 sterol isomerase and is biochemically related to the CHILD syndrome. Eur J Dermatol. 2000;10(6):425-428.
9. Traupe H, Müller D, Atherton D, et al. Exclusion mapping of the X-linked dominant chondrodysplasia punctata/ichthyosis/cataract/short stature (Happle) syndrome: possible involvement of an unstable pre-mutation. Hum Genet. 1992; 89(6):659-665.
10. Has C, Bruckner-Tuderman L, Müller D, et al. The Conradi-Hünermann-Happle syndrome (CDPX2) and emopamil binding protein: novel mutations, and somatic and gonadal mosaicism. Hum Mol Genet. 2000;9(13):1951-1955. (Pubitemid 30642659)
11. Happle R. Dohi Memorial Lecture: new aspects of cutaneous mosaicism. J Dermatol. 2002;29(11):681-692. (Pubitemid 35416254)
12. Happle R. Mosaicism in human skin: understanding the patterns and mechanisms. Arch Dermatol. 1993;129(11):1460-1470. (Pubitemid 23330967)
13. Erickson RP. Somatic gene mutation and human disease other than cancer: an update. Mutat Res. 2010;705(2):96-106.
14. Chemke J, Rappaport S, Etrog R. Aberrant melanoblast migration associated with trisomy 18 mosaicism. J Med Genet. 1983;20(2):135-137. (Pubitemid 13111052)
15. Paller AS, Syder AJ, Chan YM, et al. Genetic and clinical mosaicism in a type of epidermal nevus. N Engl J Med. 1994;331(21):1408-1415. (Pubitemid 24348354)
16. Hafner C, Van Oers JM, Vogt T, et al. Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi. J Clin Invest. 2006;116(8):2201-2207. (Pubitemid 44162329)
17. Colman SD, Rasmussen SA, Ho VT, Abernathy CR, Wallace MR. Somatic mosaicism in a patient with neurofibromatosis type 1. Am J Hum Genet. 1996; 58(3):484-490. (Pubitemid 26062479)
18. Hwang LY, Lee JB, Richard G, Uitto JJ, Hsu S. Type 1 segmental manifestation of Hailey-Hailey disease. J Am Acad Dermatol. 2003;49(4):712-714. (Pubitemid 37210289)
19. Wada T, Shirakata Y, Takahashi H, et al. A Japanese case of segmental Darier's disease caused by mosaicism for the ATP2A2 mutation. Br J Dermatol. 2003; 149(1):185-188. (Pubitemid 36966532)
20. Ceulen RP, Van Marion AM, Steijlen PM, Frank J, Poblete-Gutiérrez P. Multiple unilateral skin tumors suggest type 1 segmental manifestation of familial syringoma. Eur J Dermatol. 2008;18(3):285-288. (Pubitemid 351821230)
21. Poblete-Gutiérrez P, Wiederholt T, König A, et al. Allelic loss underlies type 2 segmental Hailey-Hailey disease, providing molecular confirmation of a novel genetic concept. J Clin Invest. 2004;114(10):1467-1474. (Pubitemid 40385577)
22. Jonkman MF, Pasmooij AM. Revertant mosaicism-patchwork in the skin.NEngl J Med. 2009;360(16):1680-1682.
23. Lai-Cheong JE, McGrath JA, Uitto J. Revertant mosaicism in skin: natural gene therapy. Trends Mol Med. 2011;17(3):140-148.
24. Choate KA, Lu Y, Zhou J, et al. Mitotic recombination in patients with ichthyosis causes reversion of dominant mutations in KRT10. Science. 2010;330(6000): 94-97.
25. Gottlieb B, Beitel LK, Alvarado C, Trifiro MA. Selection and mutation in the "new" genetics: an emerging hypothesis. Hum Genet. 2010;127(5):491-501.
26. Happle R. Superimposed segmental manifestation of polygenic skin disorders. J Am Acad Dermatol. 2007;57(4):690-699. (Pubitemid 47384938)
27. Rodríguez-Santiago B, Malats N, Rothman N, et al. Mosaic uniparental disomies and aneuploidies as large structural variants of the human genome. Am J Hum Genet. 2010;87(1):129-138.